0000899243-20-018257.txt : 20200702
0000899243-20-018257.hdr.sgml : 20200702
20200702160227
ACCESSION NUMBER: 0000899243-20-018257
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christenson Johan
CENTRAL INDEX KEY: 0001488771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 201009198
MAIL ADDRESS:
STREET 1: C/O ODLANDER, FREDRIKSON & CO. AB
STREET 2: STRANDVAGEN 5B
CITY: STOCKHOLM
STATE: V7
ZIP: SE-114 51
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001805890
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
BUSINESS PHONE: 289-799-0891
MAIL ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
0
0001805890
Fusion Pharmaceuticals Inc.
FUSN
0001488771
Christenson Johan
C/O FUSION PHARMACEUTICALS INC.
270 LONGWOOD ROAD SOUTH
HAMILTON
A6
L8P 0A6
ONTARIO, CANADA
1
0
0
0
Common Shares
2020-06-30
4
C
0
2497345
A
2497345
I
See Footnote
Common Shares
2020-06-30
4
C
0
1069902
A
3567247
I
See Footnote
Common Shares
2020-06-30
4
P
0
240000
17.00
A
3807247
I
See Footnote
Class A Preferred Exchangeable Shares
2020-06-30
4
C
0
13333333
D
Common Shares
2497345
0
I
See Footnote
Class B Preferred Exchangeable Shares
2020-06-30
4
C
0
5712216
D
Common Shares
1069902
0
I
See Footnote
Represents Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited are redeemable into Class A Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class A Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. The Class A Preferred Exchangeable Shares have no expiration date.
The securities are held directly by HealthCap VII, L.P. ("HCLP"). HealthCap VII GP SA ("HCSA") is the sole general partner of HCLP and has voting and investment control over the Shares and Preferred Stock held by HCLP. The reporting person has an indirect interest in HCSA and is an employee of HealthCap VII Advisor AB. The reporting person disclaims beneficial ownership of Shares and Preferred Stock held by HCLP except to the extent of any pecuniary interest therein.
Represents Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited are redeemable into Class B Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class B Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. The Class B Preferred Exchangeable Shares have no expiration date.
/s/ John Crowley, Attorney-in-Fact
2020-07-02